Related Experiment Videos
Thallium 201 for assessment of myocardial viability
1Cardiology Branch, National Heart, Lung, and Blood Institute, Bethesda, MD 20892.
Insights
Identifying viable heart muscle in coronary artery disease patients is key. Thallium reinjection imaging accurately predicts improved heart function after procedures, offering a cost-effective alternative to PET scans.
Area of Science:
- Cardiology
- Nuclear Medicine
- Medical Imaging
Background:
- Left ventricular (LV) dysfunction in chronic coronary artery disease (CAD) often stems from viable but under-perfused myocardium, not just scar tissue.
- Identifying this hibernating myocardium is crucial as it can recover function post-revascularization.
- Standard thallium-201 scintigraphy may inaccurately classify viable tissue as irreversibly damaged.
Purpose of the Study:
- To evaluate the efficacy of advanced thallium imaging techniques in identifying viable myocardium in patients with CAD and LV dysfunction.
- To compare the accuracy of thallium reinjection imaging with positron emission tomography (PET) in predicting functional recovery.
Main Methods:
- Utilized thallium-201 scintigraphy with delayed redistribution (4-hour and 24-hour imaging).
- Employed thallium reinjection techniques to assess myocardial viability in regions with initially fixed defects.
- Compared thallium imaging results with positron emission tomography (PET) in a subset of patients.
Main Results:
- Thallium reinjection imaging demonstrated thallium uptake in dysfunctional regions with initially fixed defects, predicting post-revascularization improvement.
- The predictive accuracy of thallium reinjection was comparable to that of metabolic imaging with PET.
- Initial comparative studies suggest concordant results between PET and single photon emission computed tomography (SPECT) thallium imaging.
Conclusions:
- Thallium reinjection imaging is a clinically accurate and cost-effective method for identifying viable myocardium in patients with chronic CAD and LV dysfunction.
- This technique offers a valuable alternative to PET for assessing myocardial viability.
- Further large-scale studies are warranted to confirm these findings.
Abstract:
Left ventricular (LV) performance is reduced in a large subset of patients with chronic coronary artery disease (CAD) and LV dysfunction on the basis of regionally ischemic or hibernating myocardium rather than irreversibly infarcted tissue. The detection of dysfunctional but viable myocardium is clinically relevant since regional and global LV function in such patients will improve after revascularization procedures; however, the identification of patients with such potentially reversible LV dysfunction is difficult. Although thallium 201 imaging may be of value in detecting viable myocardium if regions with perfusion defects during exercise demonstrate redistribution of thallium on a 3- to 4-hour resting image, thallium defects often appear persistently "fixed" within regions of severely ischemic or hibernating myocardium. It has been shown that up to 50% of regions with apparently irreversible thallium defects will improve in function after revascularization. Thus, standard exercise-redistribution thallium scintigraphy may not differentiate LV dysfunction arising from infarcted versus hibernating myocardium. The precision with which thallium imaging identifies viable myocardium can be improved greatly by additional studies once 4-hour redistribution imaging demonstrates an irreversible thallium defect. These additional studies include late (24-hour) redistribution imaging, repeat imaging after thallium reinjection, or a combination of thallium reinjection followed by late imaging. Several recent studies suggest that thallium reinjection techniques, by demonstrating thallium uptake in dysfunctional regions with apparently irreversible defects, predict improvement after revascularization with similar predictive accuracy as that achieved using metabolic imaging with positron emission tomography (PET). Studies directly comparing such thallium methods and PET, which thus far involve only small numbers of patients, suggest that the assessment of regional metabolic activity using PET and the assessment of regional thallium activity using single photon emission computed tomography provide concordant results. These findings, if confirmed by larger ongoing studies, suggest that thallium reinjection imaging is a convenient, clinically accurate, and relatively inexpensive method with which to identify viable myocardium in patients with chronic CAD and LV dysfunction.